2m 2m 2m 2m 2m 2m 2m
SILO PHARMA (SILO)
NASDAQ
$1.19+$0.01 (+1.19%)
Price as of Oct 22, 2026 6:00 PM EDT- $2.5MMarket Cap
- -85.21%1-Year Change
- BiotechnologyIndustry
SILO PHARMA (SILO)
$1.19+$0.01 (+1.19%)
SILO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.18 | ||
Change | -$0.02 (-1.67%) | ||
Open | $1.20 | ||
High | $1.22 | ||
Low | $1.17 | ||
Previous Close | $1.20 | ||
Volume | 23,704 | ||
30-Day Average Volume | 96,023 | ||
1-Week Change | -1.67% | ||
1-Month Change | -31.40% | ||
1-Year Change | -85.90% | ||
3-Year Change | -94.22% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 2.1M | ||
Total Assets | $6.0M | ||
Market Cap | $2.5M | ||
Enterprise Value | -$813,195.00 | ||
Period: QTR TTM FY | |||
Revenue | $5,818.00 | ||
Net Income | -$834,720.00 | ||
Free Cash Flow | -$781,861.00 | ||
EBIT | -$834,720.00 | ||
EBITDA | -$831,782.00 | ||
Net Working Capital | $4.6M | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -140 | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 06/03/2026 | ||
Earnings & Revenue